Obesity and oxidative stress: Potential roles of melatonin as antioxidant and metabolic regulator

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 14, Issue 3, 2014, Pages 159-168

  Bonnefont Rousselot, Dominique ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antioxidant; Insulin resistance; Melatonin; Metabolic syndrome; Obesity

Indexed keywords

GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC REGULATION; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; WEIGHT REDUCTION;

EID: 84911184745     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530314666140604151452     Document Type: Article

References (144)

1. Kopelman, P.G. (2000) Obesity as a medical problem. Nature, 404, 635-643.
2. Markwald, R.R.; Melanson, E.L.; Smith, M.R.; Higgins, J.; Perreault, L.; Eckel, R.H. and Wright, K.P. Jr. (2013) Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc. Natl. Acad. Sci. USA, 110, 5695- 5700.
3. de Onis, M.; Blossner, M. and Borghi, E. (2010) Global prevalence and trends of overweight and obesity among preschool children. Am. J. Clin. Nutr., 92, 1257-1264.
4. Wang, Y. and Lim, H. (2012) The global childhood obesity epidemic and the association between socio-economic status and childhood obesity. Int. Rev. Psychiatry, 24, 176-188.
5. Finucane, M.M.; Stevens, G.A.; Cowan, M.J.; Danaei, G.; Lin, J.K.; Paciorek, C.J.; Singh, G.M.; Gutierrez, H.R.; Lu, Y.; Bahalim, A.N.; Farzadfar, F.; Riley, L.M. and Ezzati M. (2011) Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet, 377, 557-567.
6. Fung, T.T.; Hu, F.B.; Yu, J.; Chu, N.F.; Spiegelman, D.; Tofler, G.H.; Willett, W.C. and Rimm, E.B. (2000) Leisure-time physical activity, television watching and plasma biomarkers of obesity and cardiovascular disease risk. Am. J. Epidemiol., 152, 1171-1178.
7. Gao, X.; Nelson, M.E. and Tucker, K.L. (2007) Television viewing is associated with prevalence of metabolic syndrome in Hispanic elders. Diabetes Care, 30, 694-700.
8. Markwald, R.R.; Melanson, E.L.; Smith, M.R.; Higgins, J.; Perreault, L.; Eckel, R.H. and Wright, K.P. Jr. (2013) Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc. Natl. Acad. Sci. USA, 110, 5695-5700.
9. Peschke, E.; Stumpf, I.; Bazwinsky, I.; Litvak, L.; Dralle, H.; Muhlbauer, E. (2007) Melatonin and type 2 diabetes - a possible link? J. Pineal Res., 42, 350-358.
10. Peschke, E.; Bahr, I. and Muhlbauer, E. (2013) Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon. Int. J. Mol. Sci., 14, 6981-7015.
11. Gardes-Albert, M.; Bonnefont-Rousselot, D.; Abedinzadeh, Z. and Jore, D. (2003) Especes reactives de l'oxygene. Comment l'oxygene peut-il devenir toxique? L'Actualité Chimique, 11-12, 91-96.
12. Rigoulet, M.; Yoboue, E.D. and Devin, A. (2011) Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling. Antioxid. Redox Signal., 14, 459-468.
13. Bisbal, C.; Lambert, K. and Avignon, A. (2010) Antioxidants and glucose metabolism disorders. Curr. Opin. Clin. Nutr. Metab. Care, 13, 439-446.
14. Hulsmans, M.; van Dooren, E. and Holvoet, P. (2012) Mitochondrial reactive oxygen species and risk of atherosclerosis. Curr. Atheroscler. Rep., 14, 264-276.
15. Grimsrud, P.A.; Picklo, M.J. Sr, Griffin T.J. and Bernlohr DA. (2007) Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell Proteomics, 6, 624-637.
16. Franco, J.G.; Lisboa, P.C.; Lima, N.S., Amaral, T.A.; Peixoto- Silva, N.; Resende, A.C.; Oliveira, E.; Passos, M.C. and Moura, E.G. (2013) Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning. J. Nutr. Biochem., 24, 960-966.
17. Atilgan, D.; Parlaktas, B.S. and Uluocak, N. (2013) Weight loss and melatonin reduce obesity-induced oxidative damage in rat testis. Adv. Urol., 2013, 836121.
18. Reiter, R.J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev., 12, 151-180.
19. Esposito, E. and Cuzzocrea, S. (2010) Antiinflammatory activity of melatonin in central nervous system. Curr. Neuropharmacol., 8: 228-242.
20. Bonnefont-Rousselot, D. and Collin, F. (2010) Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology, 278, 55-67.
21. Radogna, F., Diederich, M. and Ghibelli, L. (2010) Melatonin: a pleiotropic molecule regulating inflammation. Biochem. Pharmacol., 80, 1844-1852.
22. Kucukakin, B.; Gogenur, I.; Reiter, R.J. and Rosenberg, J. (2009) Oxidative stress in relation to surgery: is there a role for the antioxidant melatonin? J. Surg. Res., 152, 338-347.
23. El-Missiry, M.A.; Ohtman, A.I. and Alabdan, M.A. (2012) Melatonin for rotection against ionizing radiation. Current Topics in Ionizing Radiation Research, Dr. Mitsuru Nenoi (Ed.), ISBN: 978-953-51-0196-3, InTech, Available from: http://www.intechopen. com/books/current-topics-in-ionizing-radiation-research/melatoninfor- protection-against-ionizing-radiation
24. Keaney, J.F. Jr; Larson, M.G.; Vasan, R.S.; Wilson, P.W.; Lipinska, I.; Corey, D.; Massaro, J.M.; Sutherland, P.; Vita, J.A.; Benjamin, E.J., Framingham Study. (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol., 23, 434-439.
25. Morrow, J.D. (2000) The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab. Rev., 32, 377-385.
26. Block. G.; Dietrich, M.; Norkus, E.P.; Morrow, J.D.; Hudes, M.; Caan, B. and Packer, L. (2002) Factors associated with oxidative stress in human populations. Am. J. Epidemiol., 156, 274-285.
27. Davi, G.; Guagnano, M.T.; Ciabattoni, G.; Basili, S.; Falco, A.; Marinopiccoli, M.; Nutini, M.; Sensi, S. and Patrono, C. (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA, 288, 2008-2014.
28. Pipek, R.; Dankner, G.; Ben-Amotz, A. and Levy, Y. (1996) Increased plasma oxidizability in participants with severe obesity. J. Nutr. Environ. Med., 6, 267-272.
29. Chrysohoou, C.; Panagiotakos, D.B.; Pitsavos, C.; Skoumas, I.; Papademetriou, L.; Economou, M. and Stefanadis, C. (2007) The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutr. Metab. Cardiovasc. Dis., 17, 590-597.
30. Desci, T.; Molnar, D. and Koletzko, B. (1997) Reduced plasma concentrations of alpha-tocopherol and beta-carotene in obese boys. J. Pediatr., 130, 653-655.
31. Strauss, R.S. (1999) Comparison of serum concentrations of alpha tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey. J. Pediatr., 134, 160-165.
32. Salazar, D.E.; Sorge, C.L., Jordan, S.W. and Corcoran GB. (1994) Obesity decreases hepatic glutathione concentrations and markedly potentiates allyl alcohol-induced periportal necrosis in the overfed rat. Int. J. Obes., 18, 25-33.
33. Olusi, S.O. (2002) Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotective enzymes in humans. Int. J. Obes. Relat. Metab. Disord., 26, 1159- 1164.
34. Pihl, E.; Zilmer, K.; Kullisaar, T.; Kairane, C.; Magi, A. and Zilmer, M. (2006) Atherogenic inflammatory and oxidative stress markers in relation to overweight values in male former athletes. Int. J. Obes., 30, 141-146.
35. Spiegelman, B.M. and Flier, J.S. (2001) Obesity and the regulation of energy balance. Cell, 104, 531-543.
36. Lee, H.; Lee, Y.J.; Choi, H.; Ko, E.H. and Kim, JW. (2009) Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem., 284, 10601- 10609.
37. Park, H.S.; Kim, S.H.; Kim, Y.S.; Ryu, S.Y.; Hwang, J.T.; Yang, H.J.; Kim, G.H.; Kwon, D.Y. and Kim, M.S. (2009) Luteolin inhibits adipogenic differentiation by regulating PPAR gamma activation. Biofactors, 35, 373-379.
38. Calzadilla, P.; Sapochnik, D.; Cosentino, S.; Diz, V.; Dicelio, L.; Calvo, J.C. and Guerra, L.N. (2011) N-acetylcysteine reduces markers of differentiation in 3T3-L1 adipocytes. Int. J. Molec. Sci., 12, 6936-6951.
39. Hausman, D.B., and Grossman, B.M. (2008) Dietary fats and obesity, chap. 24, pp. 601-632. In: Food Lipids. Chemistry, Nutrition and Biotechnology, 3rd Edition. Akoh, C.C. and Min D.B., Eds. CRC Press, Taylor & Francis Group, Boca Raton, FL.
40. Kim, J.R.; Ryu, H.H.; Chung, H.J.; Lee, J.H.; Kim, S.W.; Kwun, W.H.; Baek, S.H. and Kim, J.H. (2006) Association of antiobesity activity of N-acetylcysteine with metallothionein-II down-regulation. Exp. Molec. Med., 38, 162-172.
41. Riccioni, G.; Speranza, L.; Pesce, M.; Cusenza, S.; D'Orazio, N. and Glade, M.J. (2012) Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition, 28, 605-610.
42. Sari, I.; Baltaci, Y.; Bagci, C.; Davutoglu, V.; Erel, O.; Celik, H.; Ozer, O.; Aksoy, N. and Aksoy, M. (2010) Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition, 26, 399-404.
43. De Marchi, E.; Baldassari, F.; Bononi, A.; Wieckowski, M.R. and Pinton, P. (2013) Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C. Oxid. Med. Cell. Longev., 2013, 564961.
44. Giorgi, C.; Agnoletto, C.; Baldini, C.; Bononi, A.; Bonora, M.; Marchi, S.; Missiroli, S.; Patergnani, S.; Poletti, F.; Rimessi, A.; Zavan, B. and Pinton, P. (2010) Redox control of protein kinase C: cell-and disease-specific aspects. Antiox. Redox Signal., 13, 1051-1085.
45. Berniakovich, I.; Trinei, M.; Stendardo, M.; Migliaccio, E.; Minucci, S.; Bernardi, P.; Pelicci, P.G. and Giorgio, M. (2008) p66Shcgenerated oxidative signal promotes fat accumulation. J. Biol. Chem., 283, 34283-34293.
46. Anderson, E.J.; Lustig, M.E.; Boyle, K.E.; Woodlief, T.L.; Kane, D.A.; Lin, C.T.; Price, J.W. 3rd; Kang, L.; Rabinovitch, P.S.; Szeto, H.H.; Houmard, J.A.; Cortright, R.N.; Wasserman, D.H. and Neufer, P.D. (2009) Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest., 119, 573-581.
47. Fleming, S.; Mackenzie, J.; Vemon, R.G.; Anderson, N.G.; Houslay, M.D. and Kilgour, E. (1998) Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiation. Biochem. J., 333, 719-727.
48. Bansode, R.R.; Huang, W.; Roy, S.K.; Mehta, M. and Mehta, K.D. (2008) Protein kinase C_ deficiency increases fatty acid oxidation and reduces fat storage. J. Biol. Chem., 283, 231-236.
49. Huang, W.; Bansode, R.; Mehta, M. and Mehta, K.D. (2009) Loss of protein kinase C_ function protects mice again diet induced obesity and development of hepatic steatosis and insulin resistance. Hepatology, 49, 1525-1536.
50. Galvez, M.I. (2011) Protein Kinase C inhibitors in the treatment of diabetic retinopathy. Curr. Pharm. Biotechnol., 12, 386-91.
51. Pinton, P.; Rimessi, A.; Marchi, S.; Orsini, F.; Migliaccio, E.; Giorgio, M.; Contursi, C.; Minucci, S.; Mantovani, F.; Wieckowski, M.R.; Del Sal, G.; Pelicci, P.G. and Rizzuto R. (2007) Protein kinase C kkand prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science, 315, 659-663.
52. Tain, Y.L.; Chen, C.C.; Lee, C.T.; Kao, Y.H.; Sheen, J.M.; Yu, H.R. and Huang, L.T. (2013) Melatonin regulates L-arginine transport and NADPH oxidase in young rats with bile duct ligation: role of protein kinase C. Pediatr. Res., 73, 395-401.
53. Alfadda, A.A. and Sallam, R.M. (2012) Reactive oxygen species in health and disease. J. Biomed. Biotechnol., article ID 936486, 14 pages.
54. Rasmussen, D.D.; Boldt, B.M.; Wilkinson, C.W.; Yellon, S.M. and Matsumoto, A.M. (1999) Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology, 140, 1009-1012.
55. Curtis, R.; Geesaman, B.J. and DiStefano, P.S. (2005) Ageing and metabolism: drug discovery opportunities. Nat. Rev. Drug Discov., 4, 569-580.
56. Wellen, K.E. and Thompson, C.B. (2010) Cellular metabolic stress: considering how cells respond to nutrient excess. Molec. Cell., 40, 323-332.
57. Stowe, D.F. and Camara, A.K.S. (2009) Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid. Redox Signal, 11, 1373- 1414.
58. Kusminski, C.M.; Holland, W.L.; Sun, K.; Park, J.; Spurgin, S.B.; Lin, Y.; Askew, G.R.; Simcox, J.A.; McClain, D.A.; Li, C. and Scherer, P.E. (2012) MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med., 18, 1539-1549.
59. Matsuzawa, Y.; Funahashi, T. and Nakamura, T. (1999) Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N. Y. Acad. Sci., 892, 146-154.
60. Wozniak, S.E.; Gee, L.L.; Wachtel, M.S. and Frezza, E.E. (2009) Adipose tissue: the new endocrine organ? A review article. Dig. Dis. Sci., 94, 1847-1856.
61. Violi, F.; Basili, S.; Nigro, C. and Pignatelli, P. (2009) Role of NADPH oxidase in atherosclerosis. Future Cardiol., 5, 83-92.
62. Loffredo, L.; Martino, F.; Carnevale, R; Pignatelli, P.; Catasca, E.; Perri, L.; Calabrese, C.M.; Palumbo, M.M.; Baratta, F.; Del Ben, M.; Angelico, F. and Violi, F. (2012) Obesity and hypercholesterolemia are associated with NOX2-generated oxidative stress and arterial dysfunction. J. Pediatr., 161, 1004-1009.
63. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M. and Shimomura, I. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 114, 1752-1761.
64. Shimomura, I.; Funahashi, T.; Takahashi, M.; Maeda, K.; Kotani, K.; Nakamura, T.; Yamashita, S.; Miura, M.; Fukuda, Y.; Takemura, K.; Tokunaga, K. and Matsuzawa, Y. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med., 2, 800-803.
65. Hotamisligil, G.S.; Shargill, N.S. and Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science, 259, 87-91.
66. Bastard, J.P.; Pieroni, L. and Hainque, B. (2000) Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab. Res. Rev., 16, 192-201.
67. Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubota, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K.; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M.L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P. and Kadowaki, T. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7, 941-946.
68. Okamoto, Y.; Kihara, S.; Ouchi, N.; Nishida, M.; Arita, Y.; Kumada, M.; Ohashi, K.; Sakai, N.; Shimomura, I.; Kobayashi, H.; Terasaka, N.; Inaba, T.; Funahashi, T. and Matsuzawa Y. (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 106, 2767-2770.
69. Bonnefont-Rousselot, D. (2002) Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care, 5, 561-568.
70. Jaffe, R., and Mani, J. (2009) Diabetes. Food and nutrients in primary practice. In: Food and Nutrients in Disease Management, chap. 18, pp. 281-300. Kohlstadt, I., Ed. CRC Press, Taylor & Francis Group, Boca Raton, FL.
71. Matsuoka, T.; Kajimoto, Y.; Watada, H.; Kaneto, H.; Kishimoto, M.; Umayahara, Y.; Fujitani, Y.; Kamada, T.; Kawamori, R. and Yamasaki, Y. (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest., 99, 144-150.
72. Rudich, A.; Tirosh, A.; Potashnik, R.; Hemi, R.; Kanety, H. and Bashan, N. (1998) Prolonged oxidative stress impairs insulininduced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes, 47, 1562-1569.
73. Nakazono, K.; Watanabe, N.; Matsuno, K.; Sasaki, J.; Sato, T. and Inoue, M. (1991) Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA, 88, 10045-10048.
74. Ohara, Y.; Peterson, T.E. and Harrison, D.G. (1993) Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest., 91, 2546-2551.
75. Mahadev, K.; Motoshima, H.; Wu, X.; Ruddy, J.M.; Arnold, R.S.; Cheng, G.; Lambeth, J.D. and Goldstein, B.J. (2004) The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol., 24, 1844-1854.
76. Angelico, F.; Loffredo, L.; Pignatelli, P.; Augelletti, T.; Carnevale, R.; Pacella, A.; Albanese, F.; Mancini, I.; Di Santo, S.; Del Ben, M. and Violi, F. (2012) Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome. Intern. Emerg. Med., 7, 219-227.
77. Bonnefont-Rousselot, D. (2004) Produits de glycation avances et hyperglycemie. Metab. Horm. Diab. Nutr., 3, 107-112.
78. Gaens, K.H.J.; Stehouwer, C.D.A. and Schalkwijk, C.G. (2010) The Nε-(carboxymethyl)lysine-RAGE axis: putative implications for the pathogenesis of obesity-related complications. Exp. Rev. Endoc. Metab., 5, 839-854.
79. Vazzana, N.; Guagnano, M.T.; Cuccurullo, C.; Ferrante, E.; Lattanzio, S.; Liani, R.; Romano, M. and Davi, G. (2012) Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. J. Clin. Endoc. Metab., 97, 1726-1730.
80. Eckel, R.H.; Barouch, W.W. and Ershow, A.G. (2002) Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation, 105, 2923-2928.
81. Mohamed-Ali, V.; Goodrick, S.; Rawesh, A.; Katz, D.R.; Miles, J.M.; Yudkin, J.S.; Klein, S. and Coppack, SW. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factoralpha, in vivo. J. Clin. Endocrinol. Metab., 82, 4196-4200.
82. Basu, S.; Whiteman, M.; Mattey, D.L. and Halliwell B. (2001) Raised levels of F2-isoprostanes and prostaglandin F2 alpha in different rheumatic diseases. Ann. Rheum. Dis., 60, 627-631.
83. Cracowski, J.L.; Bonaz, B.; Bessard, G.; Bessard, J.; Anglade, C.; and Fournet, J. (2002) Increased urinary F2-isoprostanes in patients with Crohn's disease. Am. J. Gastroenterol., 97, 99-103.
84. Ziccardi, P.; Nappo, F.; Giugliano, G.; Esposito, K.; Marfella, R.; Cioffi, M.; D'Andrea, F.; Molinari, A.M. and Giugliano, D. (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation, 105, 804-809.
85. De Ferranti, S. and Rifai, N. (2002) C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin. Chim. Acta, 317, 1-15.
86. Higdon, J.V. and Frei, B. (2003) Obesity and oxidative stress: a direct link to CVD? Arterioscler. Thromb. Vasc. Biol., 23, 365-367.
87. Roh, C.; Jung, U. and Jo, S.-K. (2012) Screening of Anti-Obesity Agent from Herbal Mixtures. Molecules, 17, 3630-3638.
88. Choi, H.D.; Kim, J.H.; Chang, M.J.; Kyu-Youn, Y. and Shin, W.G. (2011) Effects of astaxanthine on oxidative stress in overweight and obese adults. Phytother. Res., 25, 1813-1818.
89. Korkmaz, A.;Topal, T.; Tan, D.-X. and Reiter, R.J. (2009) Role of melatonin in metabolic regulation. Rev. Endocr. Metab. Disord., 10, 261-270.
90. Tan, D.X.; Manchester, L.C.; Fuentes-Broto, L.; Paredes, S.D. and Reiter, R.J. (2011) Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes. Rev., 12,167-188.
91. Reiter, R.J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev., 12, 151-180.
92. Brzezinski, A. (1997) Mechanism of disease: melatonin in humans. N. Engl. J. Med., 336, 186-195.
93. Reiter, R.J.; Tan, D.X.; Gitto, E.; Sainz, R.M.; Mayo, J.C.; Leon, J.; Manchester, L.C.; Vijayalaxmi; Kilic, E. and Kilic, U. (2004) Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol. J. Pharmacol., 56, 159-170.
94. Reiter, R.J.; Paredes, S.D.; Manchester, L.C. and Tan, D.X. (2009) Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol., 44, 175-200.
95. Galano, A.; Tan, D.X. and Reiter, R.J. (2011) Melatonin as a natural ally against oxidative stress: a physiochemical study. J. Pineal Res., 51, 1-16.
96. Bonnefont-Rousselot, D.; Collin, F.; Jore, D. and Gardes-Albert M. (2011) Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J. Pineal Res., 50, 328-335.
97. Tan, D.X.; Manchester, L.C.; Terron, M.P.; Flores, L.J. and Reiter, R.J. (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res., 42, 28-42.
98. Peyrot, F. and Ducrocq, C. (2008) Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J. Pineal Res., 45, 235-246.
99. Hardeland, R. (2011) Melatonin and its metabolites as antinitrosating and antinitrating agents. J. Exp. Integr. Med., 1, 67-81.
100. Korkmaz, A. and Manchester, L.C. (2011) Reactive nitrogen species; devastating intracellular players and melatonin as a defender. J. Exp. Integr. Med., 1, 63-65.
101. Barlow-Walden, L.R.; Reiter, R.J.; Abe, M.; Pablos, M.; Menendez-Pelaez, A.; Chen, L.D. and Poeggeler, B. (1995) Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int., 26, 497-502.
102. Pablos, M.I.; Agapito, M.T.; Gutierrez, R.; Recio, J.M.; Reiter, R.J.; Barlow-Walden, L.; Acuna-Castroviejo, D. and Menendez- Pelaez, A. (1995) Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J. Pineal Res., 19, 111-115.
103. Pablos, M.I.; Reiter, R.J.; Ortiz, G.G.; Guerrero, J.M.; Agapito, M.T.; Chuang, J.I. and Sewerynek, E. (1998) Rhythms of glutathione peroxidase and glutathione reductase in the brain of chick and their inhibition by light. Neurochem. Int., 32, 69-75.
104. Winiarska, K.; Fraczyk, T.; Malinska, D.; Drozak, J. and Bryla, J. (2006) Melatonin attenuates diabetes-induced oxidative stress in rabbits. J. Pineal Res., 40, 168-176.
105. Korkmaz, A.; Rosales-Corral, S. and Reiter, R.J. (2012) Gene regulation by melatonin linked to epigenetic phenomena. Gene, 503, 1-11.
106. de Vries, H.E.; Witte, M.; Hondius, D.; Rozemuller, A.J.; Drukarch, B.; Hoozemans, J. and van Horssen, J. (2008) Nrf2- induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic. Biol. Med., 45, 1375-1383.
107. Li, W. and Kong, A.N. (2009) Molecular mechanisms of Nrf2- mediated antioxidant response. Mol. Carcinog., 48, 91-104.
108. Li, W.; Thakor, N.; Xu, E.Y.; Huang, Y.; Chen, C.; Yu, R.; Holcik, M. and Kong, A.N. (2010) An internal ribosomal entry site mediates redox-sensitive translation of Nrf2. Nucleic Acids Res., 38, 778-788.
109. Prunet-Marcassus, B.; Desbazeille, M.; Bros, A.; Louche, K.; Delagrange, P.; Renard, P.; Casteilla, L. and Penicaud, L. (2003) Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology, 144, 5347-5352.
110. Wolden-Hanson, T.; Mitton, D.R.; McCants, R.L.; Yellon, S.M.; Wilkinson, C.W.; Matsumoto, A.M. and Rasmussen, D.D. (2000) Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology, 141, 487-497.
111. Puchalski, S.S.; Green, J.N. and Rasmussen, D.D. (2003) Melatonin effect on rat body weight regulation in response to highfat diet at middle age. Endocrine, 21, 163-167.
112. Prunet-Marcassus, B.; Desbazeille, M.; Bros, A.; Louche, K.; Delagrange, P.; Renard, P.; Casteilla, L. and Penicaud, L. (2003) Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology, 144, 5347-5352.
113. Pan, M.; Song, Y.L.; Xu, J.M. and Gan HZ. (2006) Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. J. Pineal Res., 41: 79-84.
114. Deng, W.G.; Tang, S.T.; Tseng, H.P. and Wu, K.K. (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood, 108, 518-524.
115. Li, J.H.; Yu, J.P.; Yu, H.G.; Xu, X.M.; Yu, L.L.; Liu, J. and Luo, H.S. (2005) Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators Inflamm., 2005, 185-193.
116. Mauriz, J.L.; Collado, P.S.; Veneroso, C.; Reiter, R.J. and Gonzalez-Gallego, J. (2013) A review of the molecular aspects of melatonin's antiinflammatory actions : recent insights and new perspectives. J. Pineal. Res., 54, 1-14.
117. Dominguez-Rodriguez, A.; Abreu-Gonzalez, P. and Reiter, R.J. (2009) Clinical aspects of melatonin in the acute coronary syndrome. Curr. Vasc. Pharmacol., 7, 367-373.
118. Kedziora-Kornatowska, K.; Szewczyk-Golec, K.; Kozakiewicz, M.; Pawluk, H.; Czuczejko, J.; Kornatowski, T.; Bartosz, G. and Kedziora, J. (2009) Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J. Pineal Res., 46, 333-337.
119. Vivekananthan, D.P.; Penn, M.S.; Sapp, S.K.; Hsu, A. and Topol, E.J. (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet, 361, 2017-2023.
120. Miller, 3rd E.R.; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R.A.; Appel, L.J. and Guallar, E. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med., 142, 37-46.
121. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G. and Gluud, C. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA, 297, 842-857.
122. Favero, G.; Rodella, L.F., Reiter, R.J. and Rezzani R. (2013) Melatonin and its atheroprotective effects: A review. Mol. Cell. Endocrinol., 382, 926-937.
123. Tan, D.X.; Manchester, L.C.; Fuentes-Broto, L.; Paredes, S.D. and Reiter, R.J. (2011) Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes. Rev., 12, 167-188.
124. Lamont, K.T.; Somers, S.; Lacerda, L.; Opie, L.H. and Lecour, S. (2011) Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection. J. Pineal Res., 50, 374-380.
125. Srinivasan, V.; Ohta, Y.; Espino, J.; Pariente, J.A.; Rodriguez, A.B.; Mohamed, M. and Zakaria, R. (2013) Metabolic syndrome, its pathophysiology and the role of melatonin. Recent Pat. Endocr. Metab. Immune Drug Discov., 7, 11-25.
126. Nduhirabandi, F.; du Toit, E.F. and Lochner, A. (2012) Melatonin and the metabolic syndrome: a tool for effective therapy in obesityassociated abnormalities? Acta Physiol. (Oxf.), 205, 209-223.
127. Cardinali, D.P.; Bernasconi, P.A.; Reynoso, R.; Toso, C.F. and Scacchi, P. (2013) Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats. Int. J. Mol. Sci., 14, 2502-2514.
128. Cannon, B., and Nedergaard, J. Brown Adipose Tissue: Function and Physiological Significance (2004). Physiol. Rev., 84, 277-359.
129. Astrup, A.; Bulow, J.; Madsen, J. and Christensen, N.J. (1985) Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am. J. Physiol., 248, E507-E515.
130. Au-Yong, I.T.; Thorn, N.; Ganatra, R.; Perkins, A.C. and Symonds, M.E. (2009) Brown adipose tissue and seasonal variation in humans. Diabetes, 58, 2583-2587.
131. Zingaretti, M.C.; Crosta, F.; Vitali, A.; Guerrieri, M.; Frontini, A.; Cannon, B.; Nedergaard, J. and Cinti, S. (2009) The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J., 23, 3113-3120.
132. Cypess, A.M.; Lehman, S.; Williams, G.; Tal, I.; Rodman, D.; Goldfine, A.B.; Kuo, F.C.; Palmer, E.L.; Tseng, Y.H.; Doria, A.; Kolodny, G.M. and Kahn, C.R. (2009) Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med., 360, 1509-1517.
133. Saito, M.; Okamatsu, Y.; Matsushita, M.; Watanabe, K.; Yoneshiro, T.; Nio-Kobayashi, J.; Iwanaga, T.; Miyagawa, M.; Kameya, T.; Nakada, K.; Kawai, Y. and Tsujisaki, M. (2009) High incidence of metabolically active brown adipose tissue in healthy humans: effects of cold exposure and adiposity. Diabetes, 58, 1526-1531.
134. Jimenez-Aranda, A.; Fernandez-Vazquez, G.; Campos, D.; Tassi, M.; Velasco-Perez, L.; Tan, D.X.; Reiter, R.J. and Agil, A. (2013) Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J. Pineal Res., 55, 416-423.
135. Liang, H. and Ward, W.F. (2006) PGC-1 alpha: a key regulator of energy metabolism. Adv. Physiol. Educ., 30, 145-151.
136. Alonso-Vale, M.I.; Peres, S.B.; Vernochet, C.; Farmer, S.R. and Lima, F.B. (2009) Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity. J. Pineal Res., 47, 221-227.
137. de Luxan-Delgado, B.; Caballero, B.; Potes, Y.; Rubio-Gonzalez, A.; Rodriguez, I.; Gutierrez-Rodriguez, J.; Solano, J.J. and Coto- Montes, A. (2013) Melatonin administration decreases adipogenesis in the liver of ob/ob mice through autophagy modulation. J. Pineal Res. [Epub ahead of print].
138. Coto-Montes, A.; Boga, J.A.; Rosales-Corral, S.; Fuentes-Broto, L.; Tan, D.X. and Reiter, R.J. (2012) Role of melatonin in the regulation of autophagy and mitophagy: a review. Mol. Cell Endocrinol., 361, 12-23.
139. Zhang, Y.; Zeng, X. and Jin, S. (2012) Autophagy in adipose tissue biology. Pharmacol. Res., 66, 505-512.
140. Younce, C.W. and Kolattukudy, P.E. (2010) MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zincfinger protein, MCPIP. Biochem. J., 426, 43-53.
141. Zhang, L.; Su, P.; Xu, C., Chen, C.; Liang, A.; Du, K.; Peng, Y. and Huang, D. (2010) Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression. J. Pineal Res., 49, 364-372.
142. Kozirog, M.; Poliwczak, A.R.; Duchnowicz, P.; Koter-Michalak, M.; Sikora, J. and Broncel, M. (2011) Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J. Pineal Res., 50, 261- 266.
143. Reiter, R.J.; Tan, D.X.; Korkmaz, A. and Ma, S. (2012) Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann. Med., 44, 564-577.
144. Cipolla-Neto, J.; Amaral, F.G.; Afeche, S.C.; Tan, D.X. and Reiter, R.J. (2014) Melatonin, energy metabolism, and obesity: a review. J. Pineal Res., 56, 371-381.